Loading...

ATNM ACTINIUM PHARMACEUTICALS INC Management Changes 8-K Filing

CTNM

TNM

ACTINIUM PHARMACEUTICALS INC

(ATNM)

2023 8-K

Voting Frequency Update

Management Changes

Annual Meeting Results

Director Elections

Director Appointment

Regulatory Update

Election of Class I Directors

Regulation FD Disclosure

Phase 3 SIERRA trial results

External Links:

Actinium Pharmaceuticals, Inc. held its 2023 annual meeting of stockholders, where David Nicholson and Richard I. Steinhart were elected as Class I directors for a three-year term.

AI Assistant

ACTINIUM PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.